RBM5 and small cell lung carcinoma: Recently, our group demonstrated that this decline in RBM5 expression may be a key step in the establishment of the transformed state of lung cells; RBM5 is responsible for slowing the cell cycle, promoting apoptosis, and downregulating transformation-associated processes such as angiogenesis in SCLC cells [9].